Immature and transitional B cells are latency reservoirs for a gammaherpesvirus

Journal of Virology

Volumn 84, Issue 24, 2010, Pages 13045-13052

  Coleman, Carrie B ^a   Nealy, Michael S ^a   Tibbetts, Scott A ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; DISEASE COURSE; GAMMAHERPESVIRINAE; HERPES VIRUS INFECTION; IMMATURITY; MOUSE; MURINE GAMMAHERPESVIRUS 68; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN; VIRUS GENOME; VIRUS LATENCY;

ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; HERPESVIRIDAE INFECTIONS; HUMANS; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PRECURSOR CELLS, B-LYMPHOID; RHADINOVIRUS; SPLEEN; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; MURID HERPESVIRUS 4; MURINAE;

EID: 78649409638     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01455-10     Document Type: Article

References (44)

1. Allman, D. M., S. E. Ferguson, V. M. Lentz, and M. P. Cancro. 1993. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431-4444.
2. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:6834-6840.
3. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20:149-157.
4. Bertolini, L., F. Falzetti, G. Lanzilli, O. Moscone, M. Longo, C. Bangrazi, and G. Gorini. 1991. Lymphocyte receptors as differentiation markers in a cell line autonomously arisen "in vitro" from a human normal bone marrow, p. 77-89. In R. Wegmann and M. Wegmann (ed.), Recent advances in cellular and molecular biology. Peeter Press, Leuven, Belgium.
5. Bertolini, L., M. L. Aebischer, F. Ameglio, A. Angeloni, I. Delaroche, A. Faggioni, A. Fruscalzo, G. Gorini, A. Serafino, G. Starace, and A. Tabilio. 2005. Phenotypic and genotypic characteristics of new euploid-diploid lymphoblastoid B cell lines EBV+, normal human bone marrow derived, spontaneously overgrown in vitro. J. Virol. Methods 126:91-100. (Pubitemid 40558748)
6. Caldwell, R. G., R. C. Brown, and R. Longnecker. 2000. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EμLMP2A transgenic mice. J. Virol. 74:1101-1113.
7. Cardin, R. D., J. W. Brooks, S. R. Sarawar, and P. C. Doherty. 1996. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184:863-871.
8. Chen, T., and S. D. Hudnall. 2006. Anatomical mapping of human herpesvirus reservoirs of infection. Mod. Pathol. 19:726-737.
9. Collins, C. M., J. M. Boss, and S. H. Speck. 2009. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J. Virol. 83:6484-6493.
10. Corbellino, M., L. Poirel, G. Bestetti, M. Pizzuto, J. Aubin, M. Capra, C. Bifulco, E. Berti, H. Agut, G. Rizzardini, M. Galli, and C. Parravicini. 1996. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res. Hum. Retroviruses 12:651-657.
11. Deeg, H. J., and G. Socie. 1998. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 91:1833-1844.
12. Dutia, B. M., S. J. Reid, D. D. Drummond, Y. Ligertwood, I. Bennet, W. Rietberg, O. Silvia, M. A. Jarvis, and A. A. Nash. 2009. A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo. PLoS One 4:e6492.
13. Flano, E., I. Kim, J. Moore, D. L. Woodland, and M. A. Blackman. 2003. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J. Immunol. 170:3828-3834.
14. Frizzera, G., D. W. Hanto, K. J. Gajl-Peczalska, J. Rosai, R. W. McKenna, R. K. Sibley, K. P. Holahan, and L. L. Lindquist. 1981. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 41:4262-4279.
15. Hanto, D. W., G. Frizzera, K. J. Gajl-Peczalska, and R. L. Simmons. 1985. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461-472.
16. Henry, M., A. Uthman, A. Geusau, A. Rieger, L. Furci, A. Lazzarin, P. Lusso, and E. Tschachler. 1999. Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. J. Invest. Dermatol. 113:613-616.
17. Hoang, M. P., D. B. Dawson, Z. R. Rogers, R. H. Scheuermann, and B. B. Rogers. 1998. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Hum. Pathol. 29:1074-1077.
18. Kikuta, H., Y. Sakiyama, S. Matsumoto, T. Oh-Ishi, T. Nakano, T. Nagashima, T. Oka, T. Hironaka, and K. Hirai. 1993. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 82:3259-3264. (Pubitemid 23356693)
19. Li, H., K. Ikuta, J. W. Sixbey, and S. A. Tibbetts. 2008. A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo. J. Virol. 82:8500-8508.
20. Li, Y., R. Wasserman, K. Hayakawa, and R. R. Hardy. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527-535.
21. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75-89.
22. Luppi, M., P. Barozzi, T. F. Schulz, G. Setti, K. Staskus, R. Trovato, F. Narni, A. Donelli, A. Maiorana, R. Marasca, S. Sandrini, G. Torelli, and J. Sheldon. 2000. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N. Engl. J. Med. 343:1378-1385.
23. Marques, S., S. Efstathiou, K. G. Smith, M. Haury, and J. P. Simas. 2003. Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J. Virol. 77:7308-7318.
24. McClain, K., R. Gehrz, H. Grierson, D. Purtilo, and A. Filipovich. 1988. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am. J. Pediatr. Hematol. Oncol. 10:196-205.
25. Nealy, M. S., C. B. Coleman, H. Li, and S. A. Tibbetts. 2010. Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection. J. Virol. 84:7523-7534.
26. Pavlova, B. G., H. H. Mühlberger, H. Strobl, R. Grill, A. Haslberger, F. Varga, H. Auer, R. Heinz, J. Salamon, and A. Stacher. 1995. B lymphocytes with latent EBV infection appearing in long-term bone marrow cultures (HLTBMCs) from haematological patients induce lysis of stromal microenvironment. Br. J. Haematol. 89:704-711.
27. Purtilo, D. (ed.). 1984. Immune deficiency and cancer: Epstein-Barr virus and lymphoproliferative malignancies. Plenum Medical Book Co., New York, NY.
28. Ragona, G., A. Tabilio, A. Fruscalzo, L. Annino, A. Angeloni, and L. Bertolini. 1988. Presence of EBV infected cells in the bone marrow from transplant donors, p. 231-235. In D. Ablashi, A. Ariad, G. Krueger, J. Pagano, and G. Pearson (ed.), Epstein-Barr virus and human disease. Humana Press, Clifton, NJ.
29. Reisman, R. P., and M. A. Greco. 1984. Virus-associated hemophagocytic syndrome due to Epstein-Barr virus. Hum. Pathol. 15:290-293.
30. Revoltella, R. P., E. Vigneti, A. Fruscalzo, M. Park, G. Ragona, G. Rocchi, and E. Calef. 1989. Epstein-Barr virus DNA sequences in precursor monocyte- macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. J. Gen. Virol. 70:1203-1215.
31. Risdall, R. J., R. W. McKenna, M. E. Nesbit, W. Krivit, H. H. Balfour, R. L. Simmons, and R. D. Brunning. 1979. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993-1002.
32. Shapiro, R. S., K. McClain, G. Frizzera, K. J. Gajl-Peczalska, J. H. Kersey, B. R. Blazar, D. C. Arthur, D. F. Patton, J. S. Greenberg, and B. Burke. 1988. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234-1243.
33. Sullivan, J. L., B. A. Woda, H. G. Herrod, G. Koh, F. P. Rivara, and C. Mulder. 1985. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood 65:1097-1104.
34. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:2347-2356.
35. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
36. Tibbetts, S. A., L. F. van Dyk, S. H. Speck, and H. W. Virgin. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol. 76:7125-7132.
37. Tibbetts, S. A., J. Loh, V. van Berkel, J. S. McClellan, M. A. Jacoby, S. B. Kapadia, S. H. Speck, and H. W. Virgin. 2003. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77:7696-7701.
38. Tibbetts, S. A., J. S. McClellan, S. Gangappa, S. H. Speck, and H. W. Virgin. 2003. Effective vaccination against long-term gammaherpesvirus latency. J. Virol. 77:2522-2529.
39. Watanabe, H., M. Koide, K. Fukuchi, Y. Takagi, S. Tomoyasu, N. Tsuruoka, and K. Gomi. 1997. Presence of Epstein-Barr virus genome in the bone marrow of patients with hematopoietic malignancies. Acta Haematol. 98:32-36. (Pubitemid 27248215)
40. Weck, K. E., M. L. Barkon, L. I. Yoo, S. H. Speck, and I. V. Virgin, H. W. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70:6775-6780.
41. Weck, K. E., S. S. Kim, H. W. Virgin, and S. H. Speck. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651-4661.
42. Wu, W., J. Vieira, N. Fiore, P. Banerjee, M. Sieburg, R. Rochford, W. Harrington, and G. Feuer. 2006. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108:141-151. (Pubitemid 43990622)
43. Zlokarnik, G., P. A. Negulescu, T. E. Knapp, L. Mere, N. Burres, L. Feng, M. Whitney, K. Roemer, and R. Y. Tsien. 1998. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279:84-88.
44. Zutter, M. M., P. J. Martin, G. E. Sale, H. M. Shulman, L. Fisher, E. D. Thomas, and D. M. Durnam. 1988. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529.